Ehealth: Second Life Impacts Diabetes Education & Self-Management
SLIDES
2 other identifiers
interventional
20
1 country
1
Brief Summary
The purpose of this study is to to develop and evaluate the feasibility, usability, and effect of participation in SLIDES (a virtual diabetes community in Second Life) for providing interactive diabetes education, support, and resources.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable type-2-diabetes
Started Jan 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2010
CompletedFirst Posted
Study publicly available on registry
August 23, 2010
CompletedStudy Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedMarch 6, 2015
March 1, 2015
1.6 years
August 19, 2010
March 4, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Perceived Usefulness
3 and 6 months
Perceived Ease of Use
3 and 6 months
Process data
January 2011 through May 2012
Secondary Outcomes (3)
Demographics
baseline
Metabolic Indicators
baseline, 3 months, 6 months
Diabetes knowledge
baseline, 3 months, 6 months
Interventions
determine the feasibility and acceptability of an eHealth program that provides diabetes education and self-management support.
Eligibility Criteria
You may qualify if:
- current Duke Endocrinology patient
- are between 21 and 75 years old
- are able to speak and read English
- are computer literate (have used a computer for at least 6 months)
- understand how to use the Internet (have accessed the Internet on at least 6 occasions)
- have access to a computer with a non-dial-up Internet connection in a private location (home)
- are mentally capable of informed consent
- are reachable by telephone
- have no pre-existing medical condition(s) or severe diabetes related complications that would interfere with study participation (i.e., physical activity) or measures (e.g., renal failure, Stage III hypertension, severe orthopedic conditions or joint replacement scheduled within 6 months, paralysis, bleeding disorders, cancer, or receipt of pharmacologic doses of anti-coagulant medications \[warfarin\])
- are able to travel to Duke University Medical Center (DUMC) for follow-up appointments.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Constance M Johnson, PhD
Duke University School of Nursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2010
First Posted
August 23, 2010
Study Start
January 1, 2011
Primary Completion
August 1, 2012
Study Completion
August 1, 2012
Last Updated
March 6, 2015
Record last verified: 2015-03